Article Details

Innovent Biologics Seeks $422 Million in Hong Kong IPO

Retrieved on: 2018-10-15 07:37:30

Tags for this article:

Click the tags to see associated articles and topics

Innovent Biologics Seeks $422 Million in Hong Kong IPO. View article details on hiswai:

Excerpt

<div>... Singapore state investor Temasek Holdings Private Ltd., <b>Sequoia Capital</b> China, Shanghai-based Greenwoods Investment, Hong Kong-based asset ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up